ICL Group (NYSE: ICL) director reports significant stock option positions
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
ICL Group Ltd. director Yoav Doppelt has reported existing holdings of stock options over the company’s ordinary shares. One grant covers 1,055,100 underlying ordinary shares at an exercise price of $11.05 per share, expiring on March 30, 2027, and is fully vested and exercisable.
A second grant covers 1,973,684 underlying ordinary shares at an exercise price of $6.73 per share, expiring on March 6, 2030. These options vest in three equal annual installments from the March 6, 2025 grant date and are held by a trustee in Doppelt’s name.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Doppelt Yoav
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 1,055,100 shares (Direct)
Footnotes (1)
- The stock options are fully vested and exercisable. The stock options vest in three equal annual installments from the March 6, 2025, grant. Represents an exercise price of NIS 34.79, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026. The options are held by a Trustee in the name of the Reporting Person. Represents an exercise price of NIS 21.18, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.
Key Figures
Underlying shares (grant 1): 1,055,100 shares
Exercise price (grant 1): $11.05 per share
Underlying shares (grant 2): 1,973,684 shares
+2 more
5 metrics
Underlying shares (grant 1)
1,055,100 shares
Ordinary shares underlying stock options at $11.05
Exercise price (grant 1)
$11.05 per share
Stock options expiring March 30, 2027
Underlying shares (grant 2)
1,973,684 shares
Ordinary shares underlying stock options at $6.73
Exercise price (grant 2)
$6.73 per share
Stock options expiring March 6, 2030
Vesting schedule (grant 2)
3 equal annual installments
From March 6, 2025 grant date
Key Terms
Stock Options (Right to Buy), Ordinary Shares, exercise price, vest in three equal annual installments, +1 more
5 terms
Stock Options (Right to Buy) financial
"security_title: "Stock Options (Right to Buy)""
exercise price financial
"Represents an exercise price of NIS 34.79, converted to U.S. dollars"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in three equal annual installments financial
"The stock options vest in three equal annual installments from the March 6, 2025, grant."
Trustee financial
"The options are held by a Trustee in the name of the Reporting Person."
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
FAQ
What insider position does Yoav Doppelt report in ICL stock options?
Yoav Doppelt reports holding stock options over ICL ordinary shares. One grant covers 1,055,100 shares at $11.05 per share, fully vested and expiring March 30, 2027. A second grant covers 1,973,684 shares at $6.73 per share, expiring March 6, 2030.
Are Yoav Doppelt’s ICL stock options fully vested or subject to vesting?
One ICL option grant held by Yoav Doppelt is fully vested and exercisable. The other grant vests in three equal annual installments beginning from the March 6, 2025 grant date, meaning those options become exercisable gradually over three years.
What are the exercise prices and expirations of Yoav Doppelt’s ICL options?
Doppelt holds options with a $11.05 exercise price expiring March 30, 2027, over 1,055,100 shares. He also holds options with a $6.73 exercise price expiring March 6, 2030, over 1,973,684 shares, both referencing ICL ordinary shares as the underlying security.
Who holds legal title to Yoav Doppelt’s ICL stock options?
The options are held by a trustee in the name of Yoav Doppelt. This means a trustee is the record holder, while the reporting indicates they are associated with Doppelt, consistent with the disclosure regarding trustee-held options.